5 Ukrainian Neurosurgical Journal. Vol. 26, N4, 2020
http://theunj.org
Обзорная статья = Review article = Оглядова стаття
Ukr Neurosurg J. 2020;26(4):5-19
doi: 10.25305/unj.209118
Клеточная терапия при ишемическом инсульте
Ботев В.С., Гриб В.А.
К
, И-
Ф
, И-
Ф, У
Поступила в редакцию 31.07.2020
Принята к публикации 02.11.2020
Адрес для переписки:
Ботев Вячеслав Семенович,
Кафедра неврологии и
нейрохирургии, Ивано-
Франковский национальный
медицинский университет, ул.
Галицкая, 2, Ивано-Франковск,
76018, Украина, e-mail:
vyacheslav56@yahoo.co.uk
И ,
.
С , 2018 . 15
6 . Е
(rtPA)
, 10
1% .
О
. О
,
, ,
. П .
О (
, ,
), ,
(,
). П
. П 15
2015 . ,
513 . П
.
Ключевые слова: ишемический каскад; клеточная терапия; стволовые
клетки; трансплантация
Copyright © 2020 Viacheslav S. Botev, Viktoria A. Gryb
This work is licensed under a Creative Commons Attribution 4.0 International License
https://creativecommons.org/licenses/by/4.0/
Cell therapy for ischemic stroke
Viacheslav S. Botev, Viktoria A. Gryb
Department of Neurology and
Neurosurgery, Ivano-Frankivsk
National Medical University, Ivano-
Frankivsk, Ukraine
Received: 31 July 2020
Accepted: 02 November 2020
Address for correspondence:
Viacheslav S. Botev, Department
of Neurology and Neurosurgery,
Ivano-Frankivsk National Medical
University, 2 Halytska st., Ivano-
Frankivsk, 76018, Ukraine, e-mail:
vyacheslav56@yahoo.co.uk
Stroke is the second, and in some countries the third cause of mortality in
the population and one of the causes of disability in the adult population.
According to statistics, in 2018, 15 million cases of stroke and 6 million deaths
were diagnosed,
The only currently approved treatments for acute stroke are intravenous
tissue plasminogen activator (rtPA) and intra-arterial thrombectomy, which
are used in less than 10% and 1% of patients, respectively.
The literature review is devoted to the pathophysiology and molecular
mechanisms of damage in cerebral ischemia. The modern concept of two
strategies of cell therapy is discussed: neuroprotection and remodeling; the
role of stem cells in reducing local and systemic infammation, neurogenesis
and angiogenesis, increasing neuronal plasticity, and protecting the blood-
brain barrier, the role of paracrine factors and extracellular vesicles is shown.
Methods of stem cell delivery are described: direct intracerebral transplantation,
intraventricular and intrathecal, intravenous and intraarterial; the number of
cells, their type and optimal delivery time depending on the acute, subacute
and chronic periods of stroke. We also described recently designed the
radially branched deployment (RBD) device and Cleveland multiport catheter
for convection-enhanced delivery in which a cell-delivery catheter can be
deployed at various angles and depths from a single longitudinal cannula.
Finally, data on the completed 15 clinical trials from 2015 to the present, in
which 513 patients took part, are presented. A detailed analysis of the ef fcacy
and safety of cell therapy has been carried out.
Keywords: ischemic cascade; cell therapy; stem cells; stem cells delivery;
clinical trials.